Back to Search
LINDA LIAU, MD
MD
Neurological Surgery Physician
NPI: 1861417834IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurological Surgery PhysicianPrimary
Neurological Surgery
Code: 207T00000X
G76908(CA)
Surgery Physician
Surgery
Code: 208600000X
G76908(CA)
CMS Specialties
PrimaryNEUROSURGERY
Education
STANFORD UNIVERSITY SCHOOL OF MEDICINE
Class of 1991
Research & Publications (20)
Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment.
PMID 16061868·Clin Cancer Res·2005
3-trial
Tumor immunity within the central nervous system stimulated by recombinant Listeria monocytogenes vaccination.
PMID 11956085·Cancer Res·2002
7-preclinical
Identification of a human glioma-associated growth factor gene, granulin, using differential immuno-absorption.
PMID 10728698·Cancer Res·2000
7-preclinical
Treatment of a patient by vaccination with autologous dendritic cells pulsed with allogeneic major histocompatibility complex class I-matched tumor peptides. Case Report.
PMID 16817691·Neurosurg Focus·2000
5-case
Stem cell associated gene expression in glioblastoma multiforme: relationship to survival and the subventricular zone.
PMID 19655089·J Neurooncol·2010
8-other
Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis.
PMID 19573811·Cancer Cell·2009
7-preclinical
Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy.
PMID 19098899·Nat Biotechnol·2009
7-preclinical
Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System. Clinical article.
PMID 19267536·J Neurosurg·2009
4-observational
Bevacizumab and chemotherapy for recurrent glioblastoma: a single-institution experience.
PMID 19349600·Neurology·2009
8-other
Neurosphere formation is an independent predictor of clinical outcome in malignant glioma.
PMID 19353526·Stem Cells·2009
7-preclinical
Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors.
PMID 19468690·J Neurooncol·2009
7-preclinical
The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers.
PMID 19478061·Proc Natl Acad Sci U S A·2009
8-other
Relationship between gene expression and enhancement in glioblastoma multiforme: exploratory DNA microarray analysis.
PMID 18796682·Radiology·2008
8-other
Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma.
PMID 18215105·PLoS Med·2008
3-trial
Anti-tumor activity and trafficking of self, tumor-specific T cells against tumors located in the brain.
PMID 18253732·Cancer Immunol Immunother·2008
7-preclinical
Phase II pilot study of bevacizumab in combination with temozolomide and regional radiation therapy for up-front treatment of patients with newly diagnosed glioblastoma multiforme: interim analysis of safety and tolerability.
PMID 18355978·Int J Radiat Oncol Biol Phys·2008
3-trial
Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate.
PMID 18669440·N Engl J Med·2008
5-case
Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age.
PMID 18940004·BMC Med Genomics·2008
8-other
Disruption of the PACAP gene promotes medulloblastoma in ptc1 mutant mice.
PMID 18036580·Dev Biol·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 300 MEDICAL PLZ, STE 400
LOS ANGELES, CA 90095 - Phone
- (310) 825-5111
Quick Facts
- NPI
- 1861417834
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 35
- Publications
- 20
Are you this provider?
Claim Your Profile